Research Scientists

William Robert Berry

Principal Research Scientist

Ariadne Labs

wberry@hsph.harvard.edu

Links

Catalyst Profile

Bibliography

Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D.

Yu EY, Ferrario C, Linch MD, Stoeckle M, Laguerre B, Arranz JA, Todenhöfer T, Fong PC, Piulats JM, Berry W, Emmenegger U, Mourey L, Joshua AM, Mar N, Appleman LJ, Conter HJ, Gravis G, Li XT, Schloss C, Poehlein C, de Bono JS.

Eur Urol Oncol. 2024 Jun 25. PMID: 38926066

Adapting the World Health Organization's Surgical Safety Checklist to High-Income Settings: A Hybrid Effectiveness-Implementation Trial Protocol.

Turley N, Kogut K, Burian B, Moyal-Smith R, Etheridge J, Sonnay Y, Berry W, Merry A, Hannenberg A, Haynes AB, Dias RD, Hagen K, Molina G, Spruce L, Williams C, Brindle ME.

Ann Surg Open. 2024 Jun. 5(2):e436. PMID: 38911631

CheckPOINT: a simple tool to measure Surgical Safety Checklist implementation fidelity.

Moyal-Smith R, Etheridge JC, Turley N, Lim SR, Sonnay Y, Payne S, Smid-Nanninga H, Kothari R, Berry W, Havens J, Brindle ME.

BMJ Qual Saf. 2024 Mar 25. 33(4):223-231. PMID: 37734956

Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.

Fecteau RE, Koontz BF, Hoffman KE, Halabi S, Howard LE, Anand M, George DJ, Zhang T, Berry WR, Lee WR, Harrison MR, Corn PG, Armstrong AJ.

Prostate Cancer Prostatic Dis. 2024 Feb 22. PMID: 38388778

Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study.

Yu EY, Berry WR, Gurney H, Retz M, Conter HJ, Laguerre B, Fong PCC, Ferrario C, Todenhöfer T, Gravis G, Piulats JM, Emmenegger U, Shore ND, Romano E, Mourey L, Li XT, Poehlein CH, Schloss C, Appleman LJ, de Bono JS.

Eur Urol Oncol. 2024 Jun. 7(3):509-518. PMID: 37940446

Defining re-implementation.

Moyal-Smith R, Etheridge JC, Karlage A, Sonnay Y, Yuan CT, Havens JM, Brindle ME, Berry W.

Implement Sci Commun. 2023 Jun 05. 4(1):60. PMID: 37277862

Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study.

Yu EY, Kolinsky MP, Berry WR, Retz M, Mourey L, Piulats JM, Appleman LJ, Romano E, Gravis G, Gurney H, Bögemann M, Emmenegger U, Joshua AM, Linch M, Sridhar S, Conter HJ, Laguerre B, Massard C, Li XT, Schloss C, Poehlein CH, de Bono JS.

Eur Urol. 2022 07. 82(1):22-30. PMID: 35397952

Improving communication and teamwork during labor: A feasibility, acceptability, and safety study.

Weiseth A, Plough A, Aggarwal R, Galvin G, Rucker A, Henrich N, Miller K, Subramanian L, Hawrusik R, Berry W, Gullo S, Spigel L, Dever K, Loveless D, Graham K, Paek B, Shah NT.

Birth. 2022 12. 49(4):637-647. PMID: 35233810

Examining health care champions: a mixed-methods study exploring self and peer perspectives of champions.

George ER, Sabin LL, Elliott PA, Wolff JA, Osani MC, McSwiggan Hong J, Berry WR.

Implement Res Pract. 2022 Jan-Dec. 3:26334895221077880. PMID: 37091082

Targeted Transcriptome and KRAS Mutation Analysis Improve the Diagnostic Performance of EUS-FNA Biopsies in Pancreatic Cancer.

Lundy J, Gao H, Berry W, Masoumi-Moghoddam S, Jenkins BJ, Croagh D.

Clin Cancer Res. 2021 11 01. 27(21):5900-5911. PMID: 34400416

VIEW MORE PUBLICATIONS

News

Surgical safety checklists effective but challenging to implement

A new study adds to the growing body of evidence that surgical safety checklists improve patient outcomes and quality of care across countries. But they only work if people use them, and implementation can be difficult in some…

view more news